Comparing performance of primary care clinicians in the interpretation of SPIROmetry with or without Artificial Intelligence Decision support software (SPIRO-AID): a protocol for a randomised controlled trial.

Journal: BMJ open
PMID:

Abstract

INTRODUCTION: Spirometry is a point-of-care lung function test that helps support the diagnosis and monitoring of chronic lung disease. The quality and interpretation accuracy of spirometry is variable in primary care. This study aims to evaluate whether artificial intelligence (AI) decision support software improves the performance of primary care clinicians in the interpretation of spirometry, against reference standard (expert interpretation).

Authors

  • Gillian Doe
    Department of Respiratory Science, University of Leicester, Leicester, UK.
  • Ethaar El-Emir
    Harefield Respiratory Research Group, Guy's and St Thomas' NHS Foundation Trust, London; Department of Respiratory Medicine, Hillingdon Hospitals NHS Foundation Trust, London, UK.
  • George D Edwards
    Harefield Respiratory Research Group, Royal Brompton & Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, UK, London, UK.
  • Marko Topalovic
  • Rachael A Evans
    NIHR Biomedical Research Centre - Respiratory, Department of Respiratory Sciences, University of Leicester, Leicester, UK; Department of Respiratory Medicine, University Hospitals of Leicester NHS Trust, Glenfield Hospital, Leicester UK. Electronic address: re66@leicester.ac.uk.
  • Richard Russell
    Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Karl P Sylvester
    Cambridge Respiratory Physiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
  • Karolien Van Orshoven
    ARTIQ, Leuven, Belgium.
  • Anthony P Sunjaya
    Harefield Respiratory Research Group, Royal Brompton & Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, UK, London, UK.
  • David A Scott
    Southampton Health Technology Assessments Centre, University of Southampton, Southampton, UK.
  • A Toby Prevost
    Nightingale-Saunders Clinical Trials and Epidemiology Unit, Cicely Saunders Institute of Palliative Care, Policy and Rehabilitation, King's College London, London, UK.
  • Jennifer Harvey
    Harefield Respiratory Research Group, Guy's and St Thomas' NHS Foundation Trust, London; Department of Respiratory Medicine, Hillingdon Hospitals NHS Foundation Trust, London, UK.
  • Stephanie Jc Taylor
    Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
  • Nicholas S Hopkinson
    National Heart & Lung Institute, Imperial College London, London, UK.
  • Samantha S Kon
    Harefield Respiratory Research Group, Guy's and St Thomas' NHS Foundation Trust, London; Department of Respiratory Medicine, Hillingdon Hospitals NHS Foundation Trust, London, UK.
  • Ian Jarrold
    Asthma + Lung UK, London, UK.
  • Nannette Spain
    PPI Partner, London, UK.
  • Winston Banya
    Harefield Respiratory Research Group, Royal Brompton & Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, UK, London, UK.
  • William D-C Man
    National Heart and Lung Institute, Imperial College London, London, UK.